Systemic immunoglobulin light chain amyloidosis
Giampaolo Merlini(University of Pavia), Morie A. Gertz(Mayo Clinic in Arizona), Angela Dispenzieri(WinnMed), Stefan Schönland(AOL (United States)), Giovanni Palladini(University of Pavia), Philip N. Hawkins(The Royal Free Hospital), Vaishali Sanchorawala(Boston University)
Cited by 550
Related Papers
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
|New England Journal of Medicine|2018|2.9k
International uniform response criteria for multiple myeloma
|Leukemia|2006|2.6k
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
|Circulation|2016|2k
NALP3 Forms an IL-1β-Processing Inflammasome with Increased Activity in Muckle-Wells Autoinflammatory Disorder
|Immunity|2004|1.7k
CRITERIA FOR EVALUATING DISEASE RESPONSE AND PROGRESSION IN PATIENTS WITH MULTIPLE MYELOMA TREATED BY HIGH‐DOSE THERAPY AND HAEMOPOIETIC STEM CELL TRANSPLANTATION
|British Journal of Haematology|1998|1.5k